BioNTech / Pfizer vaccine against children 5-11 years old is effective and safe Covid-19, the company BioNTech announced on Monday, referring to the results of the relevant clinical research.
According to the company, the research showed that both the immune response and the side effects of the vaccine are similar to those of the 16-25 age group. Children aged 5-11 years, however, were given one-third of the 30-microgram dose, with a three-week interval between the two doses.
The data of the clinical trial will be submitted as soon as possible to the European Medicines Agency (EMA) and the corresponding American service FDA, the two companies announced. "We are delighted to be able to report the results to school-age children before the start of winter," said BioNTech co-founder Ugur Sahin. By the end of the year, the results of the studies for the ages 2-5 years and 6 months - 2 years are expected.
Source: RES-EAP
Candidate for the Municipality of the Municipality of Paralimni - Deryneia which will include the municipal apartments...
Accused of criminal offenses in connection with allegedly improperly securing €765.000 in European sponsorship to upgrade…
He is working to reach a solution based on dialogue and mutual trust, he said…
A law proposal is submitted to the upcoming Plenary Session of the Parliament, which aims to extend the transitional period...
Three days after the Eurovision final, the representative of Cyprus, Silia Kapsis, gave a…
The main reason why young people in Cyprus do not intend or are not…